The guidelines for submitting sequence listing data for national and international biotechnology patent applications are outlined in 37 CFR 1.821-1.825 and World Intellectual Property Organization (WIPO) Standard ST 25 (1998). Applicants must submit a copy of the sequence listing in the prescribed standard format and another copy that is in computer readable form. The sequence listings may be submitted on paper, compact disc, or electronically over the Internet. The USPTO uses the sequence listing to examine patent applications and to support the publication of applications and issued patents. Applicants use
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures